Randomized phase III trial of tamoxifen versus thalidomide in women with biochemical-recurrent-only epithelial ovarian, fallopian tube or primary peritoneal carcinoma after a complete response to first-line platinum/taxane chemotherapy with an evalua...
暂无分享,去创建一个
R. Mannel | M. Brady | M. Pearl | K. Tewari | W. Mcguire | D. Benbrook | Iouri Ivanov | K. Zanotti | P. Edmonds